Moolec Science (MLEC) Cash from Operations (2022 - 2024)
Moolec Science (MLEC) reported Cash from Operations of 2153878.0 for Q4 2024, up 44.83% on a YoY basis from 1487144.58 in Q1 2024, and down 91.26% sequentially from 1126149.0 in Q3 2024.
Moolec Science (MLEC) Cash from Operations (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Cash from Operations data on file, last reported at 2153878.0 in Q4 2024.
- For the quarter ending Q4 2024, Cash from Operations rose 44.83% year-over-year to 2153878.0; the trailing twelve-month figure through Dec 2024 stood at 41925394.0 (up 190.7% YoY), and the FY2025 full-year result was 3636413.0, down 90.81% from the prior year.
- Cash from Operations declined to 2153878.0 in Q4 2024, from 1126149.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 47845572.0 in Q2 2024 to a low of 36312138.0 in Q2 2023.
- A 3-year average of 494126.33 and a median of 1434856.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 18171.76% in 2023 and jumped 231.76% in 2024, its largest moves.
- Tracing MLEC's Cash from Operations over 3 years: stood at 592663.0 in 2022, then slumped by 558.77% to 3904296.0 in 2023, then surged by 44.83% to 2153878.0 in 2024.
- Business Quant data shows MLEC's Cash from Operations at 2153878.0 in Q4 2024, 1126149.0 in Q3 2024, and 47845572.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.15 Mn |
| Dec 31, 2024 | -2.15 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | 47.85 Mn |
| Jun 30, 2024 | 47.85 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Mar 31, 2024 | -2.64 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Dec 31, 2023 | -3.90 Mn |
| Sep 30, 2023 | -1.74 Mn |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | -36.31 Mn |
| Jun 30, 2023 | -36.31 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Dec 31, 2022 | -592,663.00 |
| Dec 31, 2022 | -592,663.00 |
| Sep 30, 2022 | 9,648.00 |
| Sep 30, 2022 | 9,648.00 |